Cargando…

Tumor Necrosis Factor Receptor 1 Expression Is Upregulated in Dendritic Cells in Patients with Chronic HCV Who Respond to Therapy

The present studies assessed the level of tumor necrosis factor receptor (TNFR) expression in peripheral blood mononuclear cells (PBMCs) subsets from patients with chronic HCV undergoing interferon α/ribavirin-based therapy (Ifn/R). Methods. TNFR family member mRNA expression was determined using qu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cubillas, Raul, Kintner, Katherine, Phillips, Frances, Karandikar, Nitin J., Thiele, Dwain L., Brown, Geri R.
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2010
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2989713/ https://www.ncbi.nlm.nih.gov/pubmed/21152182 http://dx.doi.org/10.1155/2010/429243

Ejemplares similares

Prevalence of HCV among people who inject drugs in Brussels—a respondent-driven sampling survey
por: Van Baelen, Luk, et al.
Publicado: (2020)

Neuroantigen-Specific Autoregulatory CD8+ T Cells Inhibit Autoimmune Demyelination through Modulation of Dendritic Cell Function
por: Kashi, Venkatesh P., et al.
Publicado: (2014)

GP73 Is Upregulated by Hepatitis C Virus (HCV) Infection and Enhances HCV Secretion
por: Hu, Longbo, et al.
Publicado: (2014)

Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti–tumor necrosis factor α therapy: Results from the British Society for Rheumatology Biologics Register
por: Dixon, W G, et al.
Publicado: (2007)

Responding to HBV and HCV in China and India: thematic series introduction
por: Manciya Mtshali, Phangisile
Publicado: (2016)

The Efficacy and Safety of Propiverine Hydrochloride in Patients with Overactive Bladder Symptoms Who Poorly Responded to Previous Anticholinergic Agents
por: Masumori, Naoya, et al.
Publicado: (2011)

Dysregulation of innate immunity in ulcerative colitis patients who fail anti-tumor necrosis factor therapy
por: Baird, Angela C, et al.
Publicado: (2016)

Risky injection practices and HCV awareness in Chiang Mai Province, Thailand: a respondent-driven sampling study of people who inject drugs
por: Prouté, Myrtille, et al.
Publicado: (2020)

Integrated treatment of hepatitis C virus infection among people who inject drugs: study protocol for a randomised controlled trial (INTRO-HCV)
por: Fadnes, Lars T., et al.
Publicado: (2019)

Respondent-driven sampling for identification of HIV- and HCV-infected people who inject drugs and men who have sex with men in India: A cross-sectional, community-based analysis
por: Solomon, Sunil S., et al.
Publicado: (2017)

Regulation of gene expression by microRNA in HCV infection and HCV–mediated hepatocellular carcinoma
por: Gupta, Priyanka, et al.
Publicado: (2014)

Leukemic Transdifferentiation of Follicular Lymphoma Into an Acute Histiocytic Leukemia in a 52-Year-Old Caucasian Woman
por: Steussy, Bryan, et al.
Publicado: (2016)

Decline in Hepatitis C Virus (HCV) Incidence in Men Who Have Sex With Men Living With Human Immunodeficiency Virus: Progress to HCV Microelimination in the United Kingdom?
por: Garvey, Lucy J, et al.
Publicado: (2020)

Evaluating interventions to reduce behaviour associated with HCV reinfection in men who have sex with men: study protocol for a non-blinded, phase 2, randomised trial
por: Hage, Kris, et al.
Publicado: (2023)

The Successful Retreatment with Glecaprevir and Pibrentasvir of Genotype 1 or 2 HCV-infected Hemodialysis Patients who Failed to Respond to NS5A and Protease Inhibitor Treatment
por: Suda, Goki, et al.
Publicado: (2018)

Dendritic Cells in HIV-1 and HCV Infection: Can They Help Win the Battle?
por: Sehgal, Mohit, et al.
Publicado: (2013)

Optimal Duration of Treatment for HCV Genotype 1 Infection in Slow Responders: A Meta-Analysis
por: Alavian, Seyed Moayed, et al.
Publicado: (2011)

A multicentre sero-behavioural survey for hepatitis B and C, HIV and HTLV among people who inject drugs in Germany using respondent driven sampling
por: Zimmermann, Ruth, et al.
Publicado: (2014)

Bacteroides fragilis enterotoxin upregulates heme oxygenase-1 in dendritic cells via reactive oxygen species-, mitogen-activated protein kinase-, and Nrf2-dependent pathway
por: Ko, Su Hyuk, et al.
Publicado: (2020)

Interleukin-1 Beta and Tumor Necrosis Factor Alpha Upregulation and Nuclear Factor Kappa B Activation in Skeletal Muscle from a Mouse Model of Chronic/Progressive Parkinson Disease
por: Erekat, Nour S., et al.
Publicado: (2018)

WHO working closely with countries responding to monkeypox
Publicado: (2022)

WHO working closely with countries responding to monkeypox
Publicado: (2022)

HOMA-AD in Assessing Insulin Resistance in Lean Noncirrhotic HCV Outpatients
por: Michalczuk, Matheus Truccolo, et al.
Publicado: (2012)

Eradication of HCV in Renal Transplant Recipients and Its Effects on Quality of Life
por: Sabbatini, Massimo, et al.
Publicado: (2018)

A randomized controlled trial for a peer-facilitated telemedicine hepatitis c treatment intervention for people who use drugs in rural communities: study protocol for the “peer tele-HCV” study
por: Herink, Megan C., et al.
Publicado: (2023)

Impact of HCV Testing and Treatment on HCV Transmission Among Men Who Have Sex With Men and Who Inject Drugs in San Francisco: A Modelling Analysis
por: Artenie, Adelina, et al.
Publicado: (2023)

Improving treatment and liver fibrosis outcomes with metformin in HCV-HIV co-infected and HCV mono-infected patients with insulin resistance: study protocol for a randomized controlled trial
por: Doyle, Mary-Anne, et al.
Publicado: (2016)

Treatment with α-Lipoic Acid over 16 Weeks in Type 2 Diabetic Patients with Symptomatic Polyneuropathy Who Responded to Initial 4-Week High-Dose Loading
por: Garcia-Alcala, Hector, et al.
Publicado: (2015)

Rapid decrease in titer and breadth of neutralizing anti-HCV antibodies in HIV/HCV-coinfected patients who achieved SVR
por: Vigón, Lorena, et al.
Publicado: (2019)

Interaction of immunosuppressants with HCV antivirals daclatasvir and asunaprevir: combined effects with mycophenolic acid
por: de Ruiter, Petra E, et al.
Publicado: (2018)

HIV and HCV Infection Status Among Drug Users — China, 2010−2018
por: Ge, Lin, et al.
Publicado: (2020)

The 'Switch’ study protocol: a randomised-controlled trial of switching to an alternative tumour-necrosis factor (TNF)-inhibitor drug or abatacept or rituximab in patients with rheumatoid arthritis who have failed an initial TNF-inhibitor drug
por: Navarro Coy, Nuria C, et al.
Publicado: (2014)

HCV incidence is associated with injecting partner age and HCV serostatus mixing in young adults who inject drugs in San Francisco
por: Page, Kimberly, et al.
Publicado: (2019)

Two-Year Follow-Up Analysis of Telaprevir-Based Antiviral Triple Therapy for HCV Recurrence in Genotype 1 Infected Liver Graft Recipients as a First Step towards Modern HCV Therapy
por: Klein, Fritz, et al.
Publicado: (2016)

Development of an IgG4-RD Responder Index
por: Carruthers, Mollie N., et al.
Publicado: (2012)

LH Pretreatment as a Novel Strategy for Poor Responders
por: Ferraretti, Anna Pia, et al.
Publicado: (2014)

Plasmacytoid Dendritic Cells Respond Directly to Apoptotic Cells by Secreting Immune Regulatory IL-10 or IFN-α
por: Simpson, Joanne, et al.
Publicado: (2016)

How Is WHO Responding to Global Public Health Threats?
Publicado: (2007)

HCV elimination among people who inject drugs. Modelling pre- and post–WHO elimination era
por: Gountas, Ilias, et al.
Publicado: (2018)

Clearance of low levels of HCV viremia in the absence of a strong adaptive immune response
por: Meyer, Manuela F, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_jkd99psodop54onkqka96mgprf